CLINICAL ROLE -
Updates in the First-Line Treatment of Advanced Renal Cell Carcinoma
Current guideline recommendations include various combinations of targeted therapy with immunotherapy.
Read More
Managing Refractory Metastatic Colorectal Cancer With Fruquintinib
In June 2020, the FDA granted a fast track designation to fruquintinib for patients with mCRC previously treated with other therapies.